Recent Finacing
Recent Raise
Santersus AG is a Zurich-based biotechnology company developing NucleoCapture, a breakthrough extracorporeal blood-purification device that selectively removes cell-free DNA and neutrophil extracellular traps to treat sepsis, autoimmune disorders, organ-transplant complications, and neurodegenerative disease.
